Significance of Small Dense Low-Density Lipoprotein as a Risk Factor for Coronary Artery Disease and Acute Coronary Syndrome

참고문헌 (61)

1. "Low-density lipoprotein subclass and its correlating factors in diabetics", 36, pp.657~61 (2003)
2. "Clinical relevance of the biochemical, metabolic, and genetic factors that influence low- density lipoprotein heterogeneity", 90, pp.30~47 (2002)
3. "Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk", 82, pp.495~506 (1990)
4. "Regulation of small dense LDL concentration in Korean and Scottish men and women", 187(93) (2002)
5. "Low-density lipoprotein particle size distribution in subjects with coronary artery disease", 28, pp.1253~9 (1998)
6. "Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins", 33, pp.1876~81 (1992)
7. "Identification of multiple subclasses of plasma low density lipoproteins in normal humans", 23, pp.97~104 (1982)
8. "Usefulness of serum total cholesterol", triglyceride ratio for predicting the presence of small, dense LDL, 2004, pp.11, 215~9
9. "Significance of small dense low- density lipoproteins and other risk factors in patients with various types of coronary heart disease", 144, pp.1026~35 (2002)
10. "Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia", 77, pp.663~72 (1986)
11. "Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity", 39, pp.1263~73 (1998)
12. "Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride- rich LDL of normal size", 269, pp.511~9 (1994)
13. "Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses", 260, pp.5067~72 (1985)
14. "Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects", 269, pp.29121~8 (1994)
15. "Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects", 11, pp.298~306 (1991)
16. "Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia", 34, pp.295~308 (1993)
17. "Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes", 84, pp.3212~6 (1999)
18. "Plasma LDL and HDL subspecies are heterogeneous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids Relevance to oxidative resistance and atherogenesis", 17, pp.786~96 (1997)
19. "Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins", 110, pp.103~10 (2001)
20. "Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Differences in intimal clearance explained by size differences", 9, pp.176~83 (1989)
21. "Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system", 123, pp.43~56 (1996)
22. "Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages", 31, pp.1387~98 (1990)
23. "Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans", 124, pp.261~71 (1996)
24. "The atherogenic lipoprotein phenotype and vascular endothelial dysfunction", 138, pp.229~35 (1998)
25. "Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The insulin Resistance Atherosclerosis Study", 19, pp.605~10 (1999)
26. "Low density lipoprotein subfractions increase thromboxane formation in endothelial cells", 192, pp.1245~50 (1993)
27. in vascular smooth muscle cells, , 1993, 118~24
28. "Association of small low-density lipoprotein particles with the incidence of coronary arterydisease in men and women", 276, pp.875~81 (1996)
29. "A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction", 276, pp.882~8 (1996)
30. "Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study", 95, pp.69~75 (1997)
31. "Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase- mediated changes in LDL density", 99, pp.1959~64 (1999)
32. "Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease", 113, pp.578~82 (1987)
33. "Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)", 42, pp.1461~7 (1993)
34. "Lipoprotein subclasses in the Monitered Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression", 16, pp.697~704 (1996)
35. "Predominance of dense low-density particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project", 94, pp.2146~53 (1996)
36. "A more meaningful scoring system for determining the severity of coronary heart disease", 51, pp.606~ (1983)
37. "Coronary risk prediction in adults (The Framingham Study)", 59, pp.91~4 (1987)
38. "Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing", 349, pp.465~73 (2003)
39. "Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimatrix Lipoprint LDL System", 47, pp.266~74 (2001)
40. "Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus", 135, pp.447~59 (2001)
41. "Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learned from kinetic studies", 9, pp.197~202 (1998)
42. "In vivo studies of VLDL metabolism and LDL heterogeneity", 19, pp.7~10 (1998)
43. "The role of small, dense low density lipoprotein (LDL): a new look", 74(1), pp.17~22 (2000)
44. "Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men", 125, pp.231~42 (1996)
45. "Low density lipoprotein particle size and coronary artery disease", 12, pp.187~95 (1992)
46. "Low-density lipoprotein subclass patterns and risk of myocardial infarction", 260, pp.1917~21 (1988)
47. "Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women", 34, pp.1687~97 (1993)
48. "Relationship of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction", 90, pp.67~80 (1991)
49. "LDL particle size distribution. Results from the Framingham Offspring Study", 12, pp.1410~9 (1992)
50. "The small, dense LDL phenotype and the risk of coronary artery disease: epidemiology, patho-physiology and therapeutic aspects", 25, pp.199~211 (1999)
51. "Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk", 106, pp.241~53 (1994)
52. "Lipoprotein analyses in patients with stable angina and acute coronary syndrome", 57, pp.161~6 (1996)
53. "Eisenberg S. Plasma triglycerides determines structure-composition in low and high density lipoproteins", 4, pp.225~31 (1984)
54. "Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population", 11, pp.1077~88 (1991)
55. "Atherogenic lipoprotein particles in atherosclerosis", 109(3), pp.32~7 (2004)
56. "Lipoprotein changes during acute coronary syndromes", 90, pp.572~ (2002)
57. "How soon after myocardial infarction should plasma lipid values be assessed?", 289, pp.1651~3 (1984)
58. "Variations in the composition of low- and high-density lipoproteins during the acute phase of myocardial infarction", 34, pp.139~40 (1988)
59. "Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial", 3, pp.587~92 (2002)
60. "Atherogenecity of lipoprotein (a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux", 143, pp.229~43 (1999)
61. "Circulating malondialdehyde- modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease", 179, pp.139~45 (2005)

관련 논문AI추천